Bohle Coating – Bohle Film Coater BFC
The BFC is the high-end version of the Bohle coater designed specifically for high speed, problem-free coating, providing unparalleled tablet uniformity and efficiencies. A high containment execution is also available.
Bohle coaters guarantee excellent product processing with exceptionally high profitability. The flat tablet bed in a long drum geometry, as well as continuous adjustment of the inclination angle ensure optimal movement of the cores. The integrated mixing spirals in the drum enable continuous product movement. There is no tablet twinning, therefore minor losses in solids and coatings.
Innovative concepts for processes as well as for cleaning improve the coater functionality and deliver outstanding results.
The type of air system reveals significant process-related advantages. Danger of spray drying of suspension no longer exists. This reduces spray losses and improves the structure of the coating. Tablets are handled more carefully thanks to the pan geometry and the mixing and conveyor elements. Through change of direction of pan rotation, tablets can be discharged completely and without containments.
The Bohle film coater BFC is the high-end version of the Bohle coater series designed specifically for high speed, problem-free coating, providing unparalleled tablet uniformity and efficiencies. A high containment execution is also available.
WEBSITE ADDRESS: www.lbbohle.com
Contact: Tobias Borgers
phone
: +49 (0) 2524 9323 150
fax
: +49 (0) 2524 9323 399
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Guidance on Quality Culture Standards
June 3rd 2025Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.
